Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.


Journal

Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355

Informations de publication

Date de publication:
09 2020
Historique:
received: 10 02 2020
revised: 30 04 2020
accepted: 14 05 2020
pubmed: 21 6 2020
medline: 2 10 2020
entrez: 21 6 2020
Statut: ppublish

Résumé

The analysis of annotated transcripts from genome-wide expression studies may help to understand the pathogenesis of complex diseases, such as systemic sclerosis (SSc). We performed a whole blood (WB) transcriptome analysis on RNA collected in the context of the European PRECISESADS project, aiming at characterising the pathways that differentiate SSc from controls and that are reproducible in geographically diverse populations. Samples from 162 patients and 252 controls were collected in RNA stabilisers. Cases and controls were divided into a discovery (n=79+163; Southern Europe) and validation cohort (n=83+89; Central-Western Europe). RNA sequencing was performed by an Illumina assay. Functional annotations of Reactome pathways were performed with the Functional Analysis of Individual Microarray Expression (FAIME) algorithm. In parallel, immunophenotyping of 28 circulating cell populations was performed. We tested the presence of differentially expressed genes/pathways and the correlation between absolute cell counts and RNA transcripts/FAIME scores in regression models. Results significant in both populations were considered as replicated. Overall, 15 224 genes and 1277 functional pathways were available; of these, 99 and 225 were significant in both sets. Among replicated pathways, we found a deregulation in type-I interferon, Toll-like receptor cascade, tumour suppressor p53 protein function, platelet degranulation and activation. RNA transcripts or FAIME scores were jointly correlated with cell subtypes with strong geographical differences; neutrophils were the major determinant of gene expression in SSc-WB samples. We discovered a set of differentially expressed genes/pathways validated in two independent sets of patients with SSc, highlighting a number of deregulated processes that have relevance for the pathogenesis of autoimmunity and SSc.

Identifiants

pubmed: 32561607
pii: annrheumdis-2020-217116
doi: 10.1136/annrheumdis-2020-217116
pmc: PMC7456554
doi:

Substances chimiques

Interferon Type I 0
Toll-Like Receptors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1218-1226

Investigateurs

Doreen Belz (D)
Eduardo Collantes-Estevez (E)
Francesca Ingegnoli (F)
Yolanda Jimenez Gómez (YJ)
Chary Lopez Pedrera (CL)
Rik Lories (R)
Gaia Montanelli (G)
Silvia Piantoni (S)
Ignasi Rodriguez Pinto (IR)
Carlos Vasconcelos (C)
Christophe Jamin (C)
Concepción Marañón (C)
Lucas Le Lann (LL)
Quentin Simon (Q)
Bénédicte Rouvière (B)
Nieves Varela (N)
Brian Muchmore (B)
Aleksandra Dufour (A)
Montserrat Alvarez (M)
Jonathan Cremer (J)
Nuria Barbarroja (N)
Velia Gerl (V)
Laleh Khodadadi (L)
Qingyu Cheng (Q)
Anne Buttgereit (A)
Aurélie De Groof (A)
Julie Ducreux (J)
Elena Trombetta (E)
Tianlu Li (T)
Damiana Alvarez-Errico (D)
Torsten Witte (T)
Katja Kniesch (K)
Nancy Azevedo (N)
Esmeralda Neves (E)
Sambasiva Rao (S)
Pierre-Emmanuel Jouve (PE)

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Ann Rheum Dis. 2018 Apr;77(4):596-601
pubmed: 29348297
Front Immunol. 2019 Jan 31;10:100
pubmed: 30804934
BMC Med Genomics. 2013;6 Suppl 2:S4
pubmed: 23819917
Nat Rev Mol Cell Biol. 2019 Apr;20(4):199-210
pubmed: 30824861
J Invest Dermatol. 2018 Apr;138(4):826-835
pubmed: 29179949
Life Sci. 1989;44(3):223-7
pubmed: 2915600
Transl Res. 2019 Jul;209:77-89
pubmed: 30876809
Am J Cancer Res. 2017 Dec 01;7(12):2350-2394
pubmed: 29312794
Ann Rheum Dis. 2018 Sep;77(9):1362-1371
pubmed: 29853453
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Brief Bioinform. 2011 May;12(3):253-8
pubmed: 21546448
Cytokine. 2020 Aug;132:154635
pubmed: 30685202
Am J Pathol. 2018 Oct;188(10):2207-2222
pubmed: 30253845
Pharmacol Ther. 2018 Dec;192:163-169
pubmed: 30081049
Ann Rheum Dis. 2010 Jun;69(6):1208-13
pubmed: 19815495
Ann Rheum Dis. 2013 Nov;72(11):1747-55
pubmed: 24092682
Epigenetics. 2017 Jun 3;12(6):433-440
pubmed: 28387599
Brief Bioinform. 2018 Nov 20;:
pubmed: 30462155
Sci Adv. 2019 Jan 23;5(1):eaau9223
pubmed: 30746468
J Biol Chem. 2007 May 25;282(21):15319-23
pubmed: 17395581
Arthritis Res. 2001;3(5):311-8
pubmed: 11549373
J Pharm Biomed Anal. 2019 Jan 5;162:82-90
pubmed: 30227356
Behav Res Methods. 2016 Dec;48(4):1560-1574
pubmed: 26487051
Lancet. 2017 Oct 7;390(10103):1685-1699
pubmed: 28413064
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Bioinformatics. 2015 Jan 1;31(1):62-8
pubmed: 25165092
IEEE Trans Vis Comput Graph. 2014 Dec;20(12):1983-92
pubmed: 26356912
J Pathol. 2018 Jan;244(1):25-35
pubmed: 28862766
Clin Genet. 2017 Oct;92(4):365-371
pubmed: 27918067
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
PLoS Comput Biol. 2012 Jan;8(1):e1002350
pubmed: 22291585
J Autoimmun. 2017 Sep;83:73-94
pubmed: 28526340
Nat Rev Genet. 2009 Jan;10(1):57-63
pubmed: 19015660
PLoS One. 2014 Dec 17;9(12):e115097
pubmed: 25517110
Arthritis Rheumatol. 2017 Mar;69(3):643-654
pubmed: 27723281
Genome Biol. 2014 Feb 03;15(2):R29
pubmed: 24485249
Curr Opin Immunol. 2013 Oct;25(5):571-8
pubmed: 24148234
Curr Rheumatol Rep. 2019 Jul 15;21(9):44
pubmed: 31304568
Curr Opin Rheumatol. 2013 Nov;25(6):686-91
pubmed: 24061076
Autoimmun Rev. 2016 Nov;15(11):1038-1045
pubmed: 27490203
Genome Biol. 2016 Jan 26;17:13
pubmed: 26813401
J Rheumatol. 2014 Mar;41(3):458-65
pubmed: 24488411
Nat Rev Rheumatol. 2019 Apr;15(4):208-224
pubmed: 30796362

Auteurs

Lorenzo Beretta (L)

Scleroderma Unit, Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy lorberimm@hotmail.com.

Guillermo Barturen (G)

GENYO, Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, PTS GRANADA, Granada, Spain.

Barbara Vigone (B)

Scleroderma Unit, Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.

Chiara Bellocchi (C)

Scleroderma Unit, Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Nicolas Hunzelmann (N)

Klinik und Poliklinik für Dermatologie und Venerologie, Uniklinik Köln, Köln, Germany.

Ellen De Langhe (E)

Division of Rheumatology, University Hospitals Leuven and Skeletal Biology and Engineering Research Center, KU Leuven, Leuven, Belgium.

Ricard Cervera (R)

Department of Autoimmune Diseases, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Maria Gerosa (M)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

László Kovács (L)

Department of Rheumatology and Immunology, University of Szeged, Faculty of Medicine, Szeged, Hungary.

Rafaela Ortega Castro (R)

Servicio de Reumatologia, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica IMIBIC, Córdoba, Spain.

Isabel Almeida (I)

Serviço de Imunologia EX-CICAP, Centro Hospitalar e Universitário do Porto, Porto, Portugal.

Divi Cornec (D)

UMR1227, Lymphocytes B et Autoimmunité, Université de Brest, Inserm, Labex IGO, Brest, France.
Rheumatology Department, Cavale Blanche Hospital, Brest, France.

Carlo Chizzolini (C)

Immunology & Allergy, University Hospital and School of Medicine (HCUGE), Geneva, Switzerland.

Jacques-Olivier Pers (JO)

UMR1227, Lymphocytes B et Autoimmunité, Université de Brest, Inserm, Labex IGO, Brest, France.

Zuzanna Makowska (Z)

Bayer Pharma AG, Berlin, Berlin, Germany.

Ralf Lesche (R)

Drug Discovery, Bayer AG, Berlin, Germany.

Martin Kerick (M)

Instituto de Parasitologia y Biomedicina Lopez-Neyra, Granada, Spain.

Marta Eugenia Alarcón-Riquelme (ME)

GENYO, Centre for Genomics and Oncological Research Pfizer, University of Granada, Andalusian Regional Government, PTS GRANADA, Granada, Spain.

Javier Martin (J)

Instituto de Parasitologia y Biomedicina Lopez-Neyra, Granada, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH